Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Telmisartan and Clopidogrel Co-administration
NCT02262650Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2004
- Primary completion
- May 2004
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan in hypertension (HTN) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity and Maximum concentration of the analyte in plasma. Started Apr 2004; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02262650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262650.